$20.700
-0.733 (-3.54%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
Should I Buy Attovia Therapeutics Inc Stock?
Attovia Therapeutics, Inc. is a good buy right now due to its recent successful IPO that raised approximately $289 million, reflecting strong market interest. The stock is currently priced at $20.70, which is significantly lower than the analyst price target of $25, suggesting a potential upside of about 20.5%. Additionally, the forward P/E ratio of 4.81 indicates that the stock may be undervalued compared to future earnings expectations. However, the main risk is the negative net income reported for Q1 2026, which stands at -18.66 million USD, indicating ongoing financial challenges.
ATTO stock price ended at $20.70 on Friday, after losing -3.54%
Attovia Therapeutics Inc (ATTO) last closed at $20.7, losing -3.54%. These facts feed the 1-day and 1-week ATTO price prediction above.
Forecast Drivers
Attovia Therapeutics Inc (ATTO) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Seasonality
Bullish
Seasonality analysis for ATTO
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.